A detailed history of Baader Bank Aktiengesellschaft transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Baader Bank Aktiengesellschaft holds 12,081 shares of PACB stock, worth $19,450. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,081
Holding current value
$19,450
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 06, 2025

BUY
$1.17 - $1.69 $14,134 - $20,416
12,081 New
12,081 $15,000
Q1 2025

May 08, 2025

BUY
$1.14 - $2.1 $70,636 - $130,120
61,962 New
61,962 $73,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $362M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Baader Bank Aktiengesellschaft Portfolio

Follow Baader Bank Aktiengesellschaft and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baader Bank Aktiengesellschaft, based on Form 13F filings with the SEC.

News

Stay updated on Baader Bank Aktiengesellschaft with notifications on news.